Semaglutide's New Indication Highlights Growing Role of GLP-1 Receptor Agonists
Pharmacy Times,
Since their first identification as therapeutic agents in 2005, glucagon-like peptide-1 receptor agonists (GLP-1s) have evolved…
Since their first identification as therapeutic agents in 2005, glucagon-like peptide-1 receptor agonists (GLP-1s) have evolved…
New Delhi: The blockbuster diabetes and obesity drug semaglutide, developed by Danish pharma giant Novo Nordisk, has already…
New Delhi: The blockbuster diabetes and obesity drug semaglutide, developed by Danish pharma giant Novo Nordisk, has already…
Study by Australian
Weight loss drugs like Ozempic and Wegovy have been everywhere in 2023. And as the injectable diabetes medication millions of…
Weight loss drugs like Ozempic and Wegovy have been everywhere in 2023. And as the injectable diabetes medication millions of…
Weight loss drugs like Ozempic and Wegovy have been everywhere in 2023. And as the injectable diabetes medication millions of…
Weight loss drugs like Ozempic and Wegovy have been everywhere in 2023. And as the injectable diabetes medication millions of…
Weight loss drugs like Ozempic and Wegovy have been everywhere in 2023. And as the injectable diabetes medication millions of…
Share on PinterestSemaglutide injections may also have cardiovascular benefits, according to a new trial.
Philadelphia – Der GLP-1-Rezeptoragonist Semaglutid reduziert das Risiko schwerer kardiovaskulärer Ereignisse bei Erwachsenen…
Hamburg – Der Nutzen von SGLT2-Inhibitoren und GLP-1-Rezeptoragonisten (RA) geht weit über die Kontrolle des Blutzuckers und…
Initially approved by the U.S. Food and Drug Administration (FDA) in 1994, metformin has been the preferred first-line glucose-lo…
Initially approved by the US Food and Drug Administration (FDA) in 1994, metformin has been the preferred first-line glucose-lowe…
I want to talk about the new weight-loss drugs, but first I have to get something off my chest.
In this video, Jeremy Faust, MD, editor-in-chief of MedPage Today, sits down with Fatima Stanford, MD, MPH, MPA, and Karl…
In this video, Jeremy Faust, MD, editor-in-chief of MedPage Today, sits down with Fatima Stanford, MD, MPH, MPA, and Karl…
Aparato para medir el nivel de azúcar en sangre. Los expertos alertan de que el 30 por ciento de los muertos por Covid-19 en…
Espanya és el cinquè país d’Europa amb més diabètics, amb 3,6 milions d’adults entre 20 i 79 anys És la primera causa de ceguesa…
1 Se lee en minutos EFE ver + Por qué confiar en El Periódico Madrid 15 de septiembre del 2021.
NEW YORK (Reuters Health) - Regardless of their exact molecular structure, glucagon-like peptide 1 (GLP-1)-receptor agonists…
September 03, 2021 2 min read Source/Disclosures Published by: Disclosures: Sattar reports consulting for Amgen, AstraZeneca…
medwireNews: An updated meta-analysis including AMPLITUDE-O supports the cardioprotective effects of glucagon-like peptide (GLP)…
A NEWER class of diabetes medications has been shown to reduce the chance of heart attacks, strokes and death from…